Inoncent Agueusop

Sanofi R&D, Industriepark Hoechst
Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Deciphering differential biomarkers for anti-interleukin-6 receptor and anti-tumour necrosis factor-α treatment response in rheumatoid arthritis by multiomics analysis.

Deciphering differential biomarkers for anti-interleukin-6 receptor and anti-tumour necrosis factor-α treatment response in rheumatoid arthritis by multiomics analysis.

Journal: RMD open

Published: February 14, 2025

Longitudinal integrated proteomic and metabolomic skin changes in patients with atopic dermatitis treated with dupilumab.

Longitudinal integrated proteomic and metabolomic skin changes in patients with atopic dermatitis treated with dupilumab.

Journal: The Journal of allergy and clinical immunology

Published: November 11, 2024

Additive efficacy of a bispecific anti-TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis.

Additive efficacy of a bispecific anti-TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis.

Journal: Science translational medicine

Published: February 01, 2023

Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin.

Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 02, 2022

Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis.

Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis.

Journal: Allergy

Published: April 28, 2022

Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist.

Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist.

Journal: Cell metabolism

Published: May 03, 2021

A Metabolomic Signature of Glucagon Action in Healthy Individuals With Overweight/Obesity.

A Metabolomic Signature of Glucagon Action in Healthy Individuals With Overweight/Obesity.

Journal: Journal of the Endocrine Society

Published: March 11, 2021

Short-term variability of the human serum metabolome depending on nutritional and metabolic health status.

Short-term variability of the human serum metabolome depending on nutritional and metabolic health status.

Journal: Scientific reports

Published: February 10, 2020

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study.

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 06, 2017

Endometriosis Leads to an Increased Trefoil Factor 3 Concentration in the Peritoneal Cavity but Does Not Alter Systemic Levels.

Endometriosis Leads to an Increased Trefoil Factor 3 Concentration in the Peritoneal Cavity but Does Not Alter Systemic Levels.

Journal: Reproductive sciences (Thousand Oaks, Calif.)

Published: June 23, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026